Computational Fluid Dynamics Analysis to Determine Shear Stresses and Rates in a Centrifugal Left Ventricular Assist Device

Overview

Journal Artif Organs

Date 2012 Feb 25

PMID 22360826

Citations 11

Authors

Brian Paul Selgrade

George A Truskey

Affiliations

Soon will be listed here.

Abstract

Axial flow left ventricular assist devices (LVADs) are a significant improvement in mechanical circulatory support. However, patients with these devices experience degradation of large von Willebrand factor (vWF) multimers, which is associated with bleeding and may be caused by high shear stresses within the LVAD. In this study, we used computational fluid mechanics to determine the wall shear stresses, shear rates, and residence times in a centrifugal LVAD and assess the impact on these variables caused by changing impeller speed and changing from a shrouded to a semi-open impeller. In both LVAD types, shear rates were well over 10,000/s in several regions. This is high enough to degrade vWF, but it is unclear if residence times, which were below 5ms in high-shear regions, are long enough to allow vWF cleavage. Additionally, wall shear stresses were below the threshold stress of 10Pa only in the outlet tube so it is feasible to endothelialize this region to enhance its biocompatibility.

Citing Articles

The dynamics of red blood cells traversing slits of mechanical heart valves under high shear.

Meng K, Chen H, Pan Y, Li Y Biophys J. 2024; 123(21):3780-3797.

PMID: 39340153 PMC: 11560308. DOI: 10.1016/j.bpj.2024.09.027.

Physical Properties of Blood and their Relationship to Clinical Conditions.

Alexy T, Detterich J, Connes P, Toth K, Nader E, Kenyeres P Front Physiol. 2022; 13:906768.

PMID: 35874542 PMC: 9298661. DOI: 10.3389/fphys.2022.906768.

A Novel Fragmentation Sensitivity Index Determines the Susceptibility of Red Blood Cells to Mechanical Trauma.

Ugurel E, Goksel E, Goktas P, Cilek N, Atar D, Yalcin O Front Physiol. 2021; 12:714157.

PMID: 34512387 PMC: 8424113. DOI: 10.3389/fphys.2021.714157.

Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy.

de Nattes T, Litzler P, Gay A, Nafeh-Bizet C, Francois A, Guerrot D PLoS One. 2020; 15(11):e0242931.

PMID: 33253314 PMC: 7703997. DOI: 10.1371/journal.pone.0242931.

Computational modeling of the Food and Drug Administration's benchmark centrifugal blood pump.

Good B, Manning K Artif Organs. 2020; 44(7):E263-E276.

PMID: 31971269 PMC: 7308203. DOI: 10.1111/aor.13643.

References

Burgreen G, Loree 2nd H, Bourque K, Dague C, Poirier V, Farrar D . Computational fluid dynamics analysis of a maglev centrifugal left ventricular assist device. Artif Organs. 2004; 28(10):874-80. DOI: 10.1111/j.1525-1594.2004.07384.x. View

Siedlecki C, Lestini B, Eppell S, Wilson D, Marchant R . Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 1996; 88(8):2939-50. View

Bourque K, Gernes D, Loree H, Richardson J, Poirier V, Barletta N . Incorporation of electronics within a compact, fully implanted left ventricular assist device. Artif Organs. 2002; 26(11):939-42. DOI: 10.1046/j.1525-1594.2002.07118.x. View

Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F . Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003; 349(4):343-9. DOI: 10.1056/NEJMoa022831. View

Curtas A, Wood H, Allaire P, McDaniel J, Day S, Olsen D . Computational fluid dynamics modeling of impeller designs for the HeartQuest left ventricular assist device. ASAIO J. 2002; 48(5):552-61. DOI: 10.1097/00002480-200209000-00019. View

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L . Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg. 2008; 86(4):1227-34. DOI: 10.1016/j.athoracsur.2008.06.030. View

Pagani F, Miller L, Russell S, Aaronson K, John R, Boyle A . Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009; 54(4):312-21. DOI: 10.1016/j.jacc.2009.03.055. View

Shim K, Anderson P, Tuley E, Wiswall E, Sadler J . Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood. 2007; 111(2):651-7. PMC: 2200832. DOI: 10.1182/blood-2007-05-093021. View

Bourque K, Gernes D, Loree 2nd H, Richardson J, Poirier V, Barletta N . HeartMate III: pump design for a centrifugal LVAD with a magnetically levitated rotor. ASAIO J. 2001; 47(4):401-5. DOI: 10.1097/00002480-200107000-00020. View

10.

Schneider S, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz R . Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A. 2007; 104(19):7899-903. PMC: 1876544. DOI: 10.1073/pnas.0608422104. View

11.

Klovaite J, Gustafsson F, Mortensen S, Sander K, Nielsen L . Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009; 53(23):2162-7. DOI: 10.1016/j.jacc.2009.02.048. View

12.

Slaughter M, Rogers J, Milano C, Russell S, Conte J, Feldman D . Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361(23):2241-51. DOI: 10.1056/NEJMoa0909938. View

13.

Wu J, Paden B, Borovetz H, Antaki J . Computational fluid dynamics analysis of blade tip clearances on hemodynamic performance and blood damage in a centrifugal ventricular assist device. Artif Organs. 2009; 34(5):402-11. PMC: 3030194. DOI: 10.1111/j.1525-1594.2009.00875.x. View

14.

Zhang X, Halvorsen K, Zhang C, Wong W, Springer T . Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science. 2009; 324(5932):1330-4. PMC: 2753189. DOI: 10.1126/science.1170905. View

15.

Steinlechner B, Dworschak M, Birkenberg B, Duris M, Zeidler P, Fischer H . Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg. 2008; 87(1):131-7. DOI: 10.1016/j.athoracsur.2008.10.027. View

16.

Achneck H, Jamiolkowski R, Jantzen A, Haseltine J, Lane W, Huang J . The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants. Biomaterials. 2010; 32(1):10-8. PMC: 4062098. DOI: 10.1016/j.biomaterials.2010.08.073. View

17.

Reininger A . VWF attributes--impact on thrombus formation. Thromb Res. 2008; 122 Suppl 4:S9-13. DOI: 10.1016/S0049-3848(08)70028-8. View

18.

Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M . Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009; 137(1):208-15. DOI: 10.1016/j.jtcvs.2008.07.032. View

19.

Letsou G, Shah N, Gregoric I, Myers T, Delgado R, Frazier O . Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005; 24(1):105-9. DOI: 10.1016/j.healun.2003.10.018. View

20.

Tock C, Bosley J, Parnis S, Clubb Jr F, Macris M, Frazier O . A genetically engineered, nonthrombogenic cellular lining for LVADs: in vitro preconditioning before in vivo implantation. ASAIO J. 1999; 45(3):172-7. DOI: 10.1097/00002480-199905000-00013. View